Skip to Content
 
Center for International Blood and Marrow Transplant Research

CT23-02

Main Content

Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall Survival

Study #: CT23-02

Study Status: Protocol Development